These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 629135)

  • 21. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
    Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
    Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experiences with depot form flupenthixol].
    Bruck J; Guss H
    Wien Med Wochenschr; 1971 Feb; 121(7):110-2. PubMed ID: 5545657
    [No Abstract]   [Full Text] [Related]  

  • 23. Agranulocytosis in the course of phenothiazine therapy: case reports.
    Yassa R
    J Clin Psychiatry; 1985 Aug; 46(8):341-3. PubMed ID: 2862136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness of treating early-onset malignant schizophrenia with psychotropic drugs and their combinations].
    Sobolev ES; Zaĭtsev SG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(1):114-21. PubMed ID: 6111878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Considerations on the use of long-acting neuroleptics in a mental health center].
    Carotti P; Merli R
    Minerva Med; 1986 Sep; 77(34-35):1577-83. PubMed ID: 2876402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of triphthazine in the treatment of mentae disorders].
    Gurowitsch IJ; Awruzki GJ
    Psychiatr Neurol Med Psychol (Leipz); 1975 May; 27(5):284-91. PubMed ID: 812131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Indications for long-term neuroleptic medication--standard procedure or individual prognosis-guided intervention? A prospective study of the clinical treatment model].
    Gaebel W; Pietzcker A
    Nervenarzt; 1983 Sep; 54(9):467-76. PubMed ID: 6138719
    [No Abstract]   [Full Text] [Related]  

  • 29. [The effect of intensive hospital treatment on the duration of remissions among schizophrenics with a long history of the disease].
    Malakhov BB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):564-8. PubMed ID: 4267491
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment-related relapses in paranoid schizophrenia].
    Smoczyński S
    Psychiatr Pol; 1973; 7(3):247-54. PubMed ID: 4728442
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses.
    Salvesen C; Vaksdal K
    Behav Neuropsychiatry; 1973 Oct-1974 Mar; 5(7-12):3-7. PubMed ID: 4154740
    [No Abstract]   [Full Text] [Related]  

  • 32. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT; Donlon PT
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical experience with depot neuroleptic treatment].
    Waldmann KD; Neumann J
    Z Arztl Fortbild (Jena); 1984; 78(20):853-6. PubMed ID: 6523910
    [No Abstract]   [Full Text] [Related]  

  • 34. [The factors influencing the effectiveness of therapy in schizophrenia and the principles of patient selection for a comparative evaluation of the results of treatment (a survey of the literature)].
    Karimov RK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):612-9. PubMed ID: 4574524
    [No Abstract]   [Full Text] [Related]  

  • 35. [Enhanced sensitivity to psychotropic preparations and its relation to organic brain insufficiency].
    Niss AI; Trubkovich MIa; Seid-Rzaev SM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(5):114-9. PubMed ID: 3414263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical aspects and course of schizophrenia from the aspect of age].
    Nadzharov RA; Shternberg EIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(9):1374-9. PubMed ID: 1179900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative clinical, social and work characteristics of patients with schizoaffective variants of schizophrenia].
    Semke AV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(1):73-7. PubMed ID: 3364102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxazepam in psychoneuroses and "anxiety bound" psychoses.
    Zador I
    Dis Nerv Syst; 1969 Oct; 30(10):688-92. PubMed ID: 5355301
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experience with Luvatren in ambulatory psychiatric patients].
    Reiter PJ
    Schweiz Arch Neurol Neurochir Psychiatr; 1969; 104(1):169-78. PubMed ID: 5801171
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experience with the early use of combined intensive drug and occupational (at an industrial enterprise) therapy of schizophrenic patients].
    Avrutskiĭ GIa; Morozova NI; Grosman AV; Kozyrev VN; Tyklina IG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(1):111-7. PubMed ID: 629134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.